ShangPharma Innovation | Peter DiLaura
team_member-template-default,single,single-team_member,postid-15870,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-10.1.1,builder-parallax-scrolling-active,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Peter DiLaura

Mr. DiLaura is a life sciences executive based in San Francisco and he currently advises a number of biotechnology and pharmaceutical companies and investors. Formerly, he was CEO of Second Genome, a pioneering microbiome therapeutics company, from seed financing through clinical development. Previously, Mr. DiLaura held a range of executive roles in the systems biology company Ingenuity Systems (Qiagen), with responsibility for commercial operations, sales and marketing, product strategy, and corporate development. He was also a Consultant at The Wilkerson Group, providing strategic consulting to biotech, pharma, medical device, and diagnostic companies and investors. He holds a BS in economics from The Wharton School at the University of Pennsylvania.